NCT00644124 Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma Status COMPLETED Phase PHASE1
NCT00637377 Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD) Status COMPLETED Phase PHASE3
NCT00610363 Study of the Safety and Effectiveness of Rilonacept for the Prevention of Gout Flares Status COMPLETED Phase PHASE2
NCT00609544 Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia Status WITHDRAWN Phase PHASE2
NCT00574275 Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer Status TERMINATED Phase PHASE3
NCT00561470 Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen Status COMPLETED Phase PHASE3
NCT00545246 A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer Patients Status COMPLETED Phase PHASE1
NCT00532155 A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00527423 Randomized, Single-Masked, Long-Term, Safety and Tolerability Study of VEGF Trap-Eye in AMD Status COMPLETED Phase PHASE2
NCT00519285 Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer Status COMPLETED Phase PHASE3
NCT00509795 Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD) Status COMPLETED Phase PHASE3
NCT00479076 A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients Status COMPLETED Phase PHASE1
NCT00396591 AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant Ascites Status COMPLETED Phase PHASE2
NCT00383370 Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMD Status COMPLETED Phase PHASE1
NCT00327444 Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites Status COMPLETED Phase PHASE2/PHASE3
NCT00327171 Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00320814 Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema Status COMPLETED Phase PHASE1
NCT00320788 Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD) Status COMPLETED Phase PHASE2
NCT00320775 Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD Status COMPLETED Phase PHASE1